Article information
Full text is only available in PDF
Bibliografía
[1.]
R. Schechter, C.P. Torfs, T.F. Bateson.
The epidemiology of infantile hypertrophic pyloric stenosis.
Paediatr Perinat Epidemiol, 11 (1997), pp. 407-427
[2.]
J.S. Janik, H.S. Nagaraj, R. Lehocky.
Piloric stenosis in identical triplets.
Pediatrics, 70 (1982), pp. 282-283
[3.]
L.E. Mitchell, N. Risch.
The genetics of infantile hypertrophic pyloric stenosis. A Reanalysis.
Am J Child, 147 (1993), pp. 1203-1211
[4.]
G. Tota, D. Meucci, F. Paciotti, M. Messina, A. Garzi, G. Di Maggio.
Stenosi hipertrofica del canale pilorico: incidenza genetica e familiare.
Pediatr Med Chir, 16 (1994), pp. 73-76
[5.]
M. Hernanz-Schulman, L.H. Lowe, J. Johnson, W.W. Neblett, D.B. Polk, J.R. Perez R, et al.
In vivo visualization of pyloric mucosal hypertrophy in infants with hypertrophic pyloric stenosis: Is there an etiologic role?.
Am J Roentgenol, 177 (2001), pp. 843-848
[6.]
A.C. Dick, J. Ardill, S.R. Potts, J.A. Dodge.
Gastrin, somatostatin and infantile hypertrophic pyloric stenosis.
Acta Paediatr, 90 (2001), pp. 879-882
[7.]
R.M. Abel.
The ontogeny of the peptide innervation of the human pylorus, with special reference to understanding the aetiology and pathogenesis of infantile hypertrophic pyloric stenosis.
J Pediatr Surg, 31 (1996), pp. 490-497
[8.]
R.M. Paredes Esteban, J. Salas Molina, J.M. Ocana Losa, M. García Ruiz.
Estudio inmunohistoquímico en la estenosis hipertrófica del píloro.
Cir Pediatr, 16 (2003), pp. 61-65
[9.]
K. Oshiro, P. Puri.
Increased insulin-like growth factor-I mRNA expresion in pyloric muscle in infantile hypertrophic pyloric stenosis.
Pediatr Surg Int, 13 (1998), pp. 253-255
[10.]
B.E. Mahon, M.B. Rosenman, M.B. Kleiman.
Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis.
J Pediatr, 139 (2001), pp. 380-384
Copyright © 2004. Asociación Española de Pediatría
